Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes

Sanjay Kalra

首页> 外文期刊>Diabetes therapy >Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes

【24h】

Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes

机译：勘误至：Auxiliendo，非原发性：比较2型糖尿病中胰岛素Degludec与胰岛素甘精的心血管安全性的DEVOTE试验的初步视图

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Diabetes therapy》 |2017年第2期|共1页
作者
Sanjay Kalra;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes [J] . Sanjay Kalra Diabetes therapy . 2017,第2期

机译：Auxiliendo，非原发性：比较2型糖尿病中胰岛素Degludec与胰岛素甘精胰岛素的心血管安全性的DEVOTE试验的初步视图
2. Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) [J] . Theilgaard Hanne, Mollerup Inger, Helmark Ida Caroe, Therapeutic innovation & regulatory science. . 2019,第2期

机译：开发，规划和进行临时分析：来自奉献心血管结果试验的课程（试验比较胰岛素Degludec的心血管安全性与胰岛素糖尿病患者在患有2型糖尿病心血管事件中的患者）
3. Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) DEVOTE 1 [J] . Marso Steven P., McGuire Darren K., Zinman Bernard, The American heart journal . 2016,第期

机译：奉献设计（试验比较胰岛素Degludec的心血管安全性VS胰岛素糖尿病患者患有2型糖尿病心血管事件的患者）奉献1
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Erratum to: Auxiliendo Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes [O] . Sanjay Kalra 2017

机译：勘误至：Auxiliendo非原发性：比较2型糖尿病中胰岛素Degludec与胰岛素甘精的心血管安全性的DEVOTE试验的初步视图
7. Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes [O] . Sanjay Kalra 2017

机译：勘误至：Auxiliendo，非原发性：比较2型糖尿病中胰岛素Degludec与胰岛素甘精的心血管安全性的DEVOTE试验的初步视图

Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes

著录项

引文网络

相似文献

相关主题

期刊订阅